CINI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 2.461
EU - Europa 560
AS - Asia 493
SA - Sud America 28
AF - Africa 7
Totale 3.549
Nazione #
US - Stati Uniti d'America 2.450
SG - Singapore 261
IT - Italia 172
IN - India 141
FI - Finlandia 88
UA - Ucraina 83
CN - Cina 78
RU - Federazione Russa 64
SE - Svezia 50
DE - Germania 27
GB - Regno Unito 22
AR - Argentina 20
IE - Irlanda 18
BE - Belgio 11
CA - Canada 11
NL - Olanda 7
FR - Francia 6
BR - Brasile 4
ES - Italia 4
CL - Cile 3
JP - Giappone 3
SC - Seychelles 3
CH - Svizzera 2
HK - Hong Kong 2
KG - Kirghizistan 2
KR - Corea 2
RO - Romania 2
TG - Togo 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IR - Iran 1
LK - Sri Lanka 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 3.549
Città #
Fairfield 342
Chandler 219
Ann Arbor 214
Woodbridge 196
Ashburn 174
Houston 141
Singapore 128
Seattle 123
Cambridge 114
Wilmington 105
San Paolo di Civitate 82
Plano 78
Princeton 78
Lawrence 62
Beijing 51
Boston 40
Fasano 35
Dearborn 34
Jacksonville 33
Millbury 33
Rome 32
San Diego 31
Santa Clara 27
Andover 24
Des Moines 23
Boardman 20
Federal 20
Dublin 18
Moscow 16
Norwalk 15
Helsinki 14
Toronto 11
Brussels 10
Falkenstein 10
Auburn Hills 7
Council Bluffs 7
Dallas 7
Falls Church 7
Bühl 6
Mannheim 6
Yubileyny 6
Nanjing 5
Hefei 4
Barcelona 3
Indiana 3
Kunming 3
Laurel 3
London 3
Milan 3
Southend 3
Springfield 3
Bishkek 2
Buffalo 2
Fuzhou 2
Lomé 2
Los Angeles 2
Muizenberg 2
New York 2
Osaka 2
Paris 2
Prineville 2
Provo 2
Redmond 2
San Mateo 2
Syracuse 2
Yellow Springs 2
Amsterdam 1
Andra 1
Baotou 1
Bern 1
Betim 1
Büdelsdorf 1
Cachoeira do Sul 1
Capão da Canoa 1
Chengdu 1
Chongqing 1
Clearwater 1
Colombo 1
Copenhagen 1
Edinburgh 1
Fort Worth 1
Hebei 1
Itapemirim 1
Jiaxing 1
Jinan 1
Lisbon 1
Mahé 1
Mumbai 1
Málaga 1
Olomouc 1
Prescot 1
San Jose 1
Santiago 1
Santiago de Cali 1
Shenyang 1
Sofia 1
Stockholm 1
Tappahannock 1
Wandsworth 1
Totale 2.695
Nome #
Redox control of viral carcinogenesis: the human papillomavirus paradigm 155
Neuropathological role of pi3k/akt/mtor axis in Down syndrome brain 98
Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study. 97
Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients 96
Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment 80
Ectopic deposition of melanin pigments as detoxifying mechanism: a paradigm for basal nuclei pigmentation 80
In vivo protective effects of ferulic acid ethyl ester against amyloid-beta peptide 1-42-induced oxidative stress. 79
Effects of uvb-induced oxidative stress on protein expression and specific protein oxidation in normal human epithelial keratinocytes: a proteomic approach. 79
Expression of human Papilloma virus type 16 E5 gene in amelanotic melanoma cells regulates endo-melanosomal pH and restores tyrosinase activity 76
UVB irradiation down-regulates HPV-16 RNA expression: Implications for malignant progression of transformed cells 76
Sex differences in brain proteomes of neuron-specific STAT3-null mice after cerebral ischemia/reperfusion. 74
Phenolics in aging and neurodegenerative disorders 73
Cysteinyldopaenkephalins: synthesis, characterization and binding to bovine brain opioid receptors. 73
Tetrahydroisoquinoline derivatives of enkephalins: synthesis and properties 72
Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects 70
Production of melanin pigments by cytochrome c/H2O2 system 67
Action of thiazolidine-2-carboxylic acid, a proline analog, on protein synthesizing systems 67
Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H : quinone oxidoreductase 1 64
Protective effect of ferulic acid ethyl ester against oxidative stress mediated by UVB irradiation in human epidermal melanocytes 63
Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer's disease neuropathology: Redox proteomics analysis of human brain 63
Proteomics analysis of protein expression and specific protein oxidation in human papillomavirus transformed keratinocytes upon UVB irradiation. 63
Tyrosinase protects human melanocytes from ROS-generating compounds 61
Redox Proteomics in Aging Rat Brain: Involvement of Mitochondrial Reduced Glutathione Status and Mitochondrial Protein Oxidation in the Aging Process 57
Protective effects of cysteinyl-DOPA on NO-mediated neurotoxicity 56
PROTEOMIC ANALYSIS OF GLYCOPROTEIC PATTERN IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER DISEASE HIPPOCAMPUS AND IPL BRAIN REGIONS 54
Heme oxygenase and cyclooxygenase in the central nervous system: A functional interplay 53
Involvement of stat3 in mouse brain development and sexual dimorphism: A proteomics approach 53
Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment 51
Doxorubicin-Induced Thymus Senescence 50
The Wheat Germ Agglutinin-Fractionated Proteome of Subjects With Alzheimer's Disease and Mild Cognitive Impairment Hippocampus and Inferior Parietal Lobule: Implications for Disease Pathogenesis and Progression 49
null 49
CYSTAMINE AND HOMOCYSTAMINE OXIDATION IN A COUPLED REACTION CATALYZED BY DIAMINEOXIDASE AND ALDEHYDE DEHYDROGENASE 48
Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: Implications for pregression of AD 46
Biological response of Human keratinocytes to ROS-producing compounds 45
Protective effect of ferulic acid ethyl ester against amyloid beta peptide (1-42)-induced oxidative stress in synaptosomes: implications for Alzheimer disease 45
Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: An investigation on the role of cellular stress response in the progression of Alzheimer disease 44
On the product of the reaction between cysteamine and 3-bromopyruvate. 40
Regulation of tyrosinase activity by dopamine-derived compounds in human primary melanocytes 40
EFFECTS OF SELENALYSINE ON CHO CELLS 40
Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice -A model of Huntington's disease 39
THIALYSINE UTILIZATION BY THIALYSINE RESISTANT CHO CELLS 37
THIALYSINE UTILIZATION FOR PROTEIN-SYNTHESIS BY AN EXPONENTIALLY GROWING ESCHERICHIA-COLI CULTURE 37
PROTEIN OXIDATION AND CELLULAR STRESS RESPONSE IN AGING BRAIN: A REDOX PROTEOMICS APPROACH 37
DT-diaphorase expression in oxidative conditions in normal and HPV-trasformed human keratinocytes 37
ON THE OXIDATION OF CYSTATHIONAMINE AND SELENOCYSTATHIONAMINE BY PLANT AMINEOXIDASE 37
Thialysine utilization for protein synthesis by CHO cells. 35
Studies on recognition of selenahomolysine by aminoacid transport systems and aminocyl-tRNA synthetase. 35
Carboxymethyl-selenopyruvic acid as the product of the oxidative deamination of carboxymethyl-selenocysteine 34
Oxidative deamination of thialysine by snake venom L-aminoacid oxidase. 34
REDOX PROTEOMIC ANALYSIS OF CARBONYLATED BRAIN PROTEIN IN MILD COGNITIVE IMPAIRMENT AND EARLY ALZHEIMER'S DISEASE 33
Thialysine- and selenalysine-resistance in a E. coli mutant. 33
Oxidative deamination of epsilon-N-acetylthialysine and epsilon-N-acetylselenalysine by snake venom L-aminoacid oxidase. 33
THE PEROXIDASE-CATALYZED OXIDATION OF KYOTORPHINS 33
Proteomic analysis for the study of amniotic fluid protein composition. 33
Synthesis and chromatographic properties of selenazolidine-2-carboxylic acid (beta-selenaproline). 33
Transport systems for lysine, thialysine and selenalysine in E. coli KL16. 33
EFFECTS OF SELENALYSINE ON THIALYSINE RESISTANT CHO CELLS 32
UV modulation of HPV 16 mRNA expression. Role of reactive oxygen species (ROS). 29
Isoquinolinic derivatives of enkephalins. 29
Repression of lysine transport in E. coli KL16. 29
Catecholamines oxidation by xantine oxidase 29
Pyridoxal phosphate catalyzed alpha-beta elimination of selenahomolysine. 29
Thialysine utilization by a lysine-requiring Escherichia coli mutant. 27
From redox proteomics to clinical practice: Search for therapeutic targets 27
Beta-selenaproline as competitive inhibitor of proline activation. 26
Transport of basic aminoacids in E. coli. 23
UTILIZATION OF SELENALYSINE BY THIALYSINE RESISTANT CHO CELLS 23
Thialysine and selenalysine utilization for protein synthesis by E. coli in comparison with lysine. 22
Oxidation of beta-DL-thiaproline, a possible natural substrate of D-aminoacid oxidase. 21
Recognition of aminoethylhomocysteine and aminopropylcysteine by aminoacid transport systems and aminoacyl tRNA synthetases. 21
Synthesis and chromatographic properties of 1,3-thiazane-2-carboxylic acid (beta-homothiaproline). 21
Selenomethionine as substrate for glutamine transaminase. 20
Oxidation of D-thiazolidine-4-carboxylic acid by hog kidney D-aminoacid oxidase. 20
Oxidative deamination of Se-(1-carboxyethyl)-,Se-(1-carboxypropyl)- and Se-(2-carboxyethyl)-selenocysteine by snake venom L-aminoacid oxidase. 20
SELENALYSINE UTILIZATION BY CHO CELLS 19
Reactive oxygen species (ROS) modulation o epithelial cells expressing high-risk HPV oncogenes 17
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology 17
Totale 3.640
Categoria #
all - tutte 11.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020190 0 0 0 0 0 0 0 0 77 58 36 19
2020/2021198 19 26 9 20 11 5 5 25 22 26 20 10
2021/2022759 36 52 66 24 93 10 11 68 61 72 112 154
2022/2023711 155 189 23 91 77 65 4 21 47 1 28 10
2023/2024224 21 41 9 5 23 22 2 3 0 37 27 34
2024/2025364 32 74 33 6 30 45 61 73 10 0 0 0
Totale 3.640